Novocure Ltd (NVCR) returns

NASDAQ · Health Care

$13.15 +0.31% Close Oct 30, 2026 Live

Novocure returns over 10 years

$1,000 invested in Novocure ten years ago was worth $2,149 at the close on October 30, 2026, with dividends reinvested: an average return of 7.9% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

NVCR, $10,000 investedS&P 500 (SPY)
$10,000$100,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month -17.6% — $824.45 -0.9%
3 months -13.7% — $863.43 +2.1%
Year to date +1.7% — $1,017 +11.7%
1 year +2.6% — $1,026 +12.4%
3 years +0.7% +0.2% $1,007 +88.5%
5 years -87.2% -33.7% $128.21 +76.0%
10 years +114.9% +7.9% $2,149 +316.6%

Novocure return by calendar year

YearNVCRS&P 500 (SPY)Difference
2026 to date +1.7% +11.7% -10.0%
2025 -56.6% +17.7% -74.3%
2024 +99.6% +24.9% +74.7%
2023 -79.6% +26.2% -105.8%
2022 -2.3% -18.2% +15.9%
2021 -56.6% +28.7% -85.4%
2020 +105.3% +18.4% +87.0%
2019 +151.7% +31.2% +120.5%
2018 +65.7% -4.6% +70.3%
2017 +157.3% +21.7% +135.6%
2016 -64.9% +12.0% -76.9%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: NVCR financials

No forecast, no recommendation. This page describes Novocure Ltd from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.